Skip to content

Clinical trials

Primary Immunodeficiency Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Primary Immunodeficiency Diseases Country / region: United States Clear all

108 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20023
20053
20064
20075
20084
20093
20104
20116
20122
20136
20146
20153
20167
20176
20184
20195
20209
20217
20223
20233
20244
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed58
Recruiting23
Active, not recruiting9
Unknown status9
Terminated6
Enrolling by invitation1
Withdrawn1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Allergy and Infectious Diseases (NIAID)16
Baxalta now part of Shire9
Grifols Therapeutics LLC7
Octapharma7
CSL Behring5
ADMA Biologics, Inc.4
Bio Products Laboratory4
New York Medical College4
Kedrion S.p.A.3
Takeda3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Primary Immunodeficiency Diseases108
Immunologic Deficiency Syndromes13
Common Variable Immunodeficiency12
Wiskott-Aldrich Syndrome11
Lymphohistiocytosis, Hemophagocytic10
Immune System Diseases9
Severe Combined Immunodeficiency8
Agammaglobulinemia7
Hyper-IgM Immunodeficiency Syndrome7
Anemia, Diamond-Blackfan6

Trials

Showing 1 to 25 of 108. Each trial links to its page on Pharma Observatory.

8 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.